Komori
TSUDAKOMA Corp. (6217) · RiskMitigated

Reduction in the Valuation of Investment Securities Due to Falling Share Prices

First written in FY2016-Q3. 10 of 29 entries say "Mitigated", first in FY2017-Q2. Latest entry: FY2026-H1.

29entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2018-Q2 – FY2019-Q3WorsenedFY2021-Q1 – FY2021-Q3MitigatedFY2022-Q3 – FY2024-Q1OtherFY2024-Q2 – FY20252016: 12017: 320172018: 420182019: 420192020: 420202021: 420212022: 120222023: 120232024: 320242025: 220252026: 22026
Same theme, other companies
Valuation Losses Due to Declines in the Market Value of Securities HeldA theme 226 companies write about · 223 as a headwind · 3 as a tailwind

TSUDAKOMA Corp. moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.

The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.

53 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥61 million ¥67 million」

    The valuation difference on available-for-sale securities increased from ¥61 million at the end of the previous consolidated fiscal year to ¥67 million.
  2. FY2025Decrease in valuation difference and continued sale of securitiesAnnual report

    「Cash flow from investing activities included proceeds of ¥193 million from the sale of investment securities, although」

    Proceeds of ¥193 million from the sale of investment securities were recorded, and the valuation difference on available-for-sale securities decreased from ¥120 million to ¥61 million.
  3. FY2025-H1Decrease in valuation difference and continued sale of securitiesAnnual report

    「Cash flow from investing activities amounted to ¥76 million, reflecting proceeds of ¥193 million from the sale of investment securities, among other items, despite payments of ¥189 million for the acquisition of property, plant and equipment and intangible assets.」

    Proceeds of ¥193 million from the sale of investment securities were recorded. The valuation difference on available-for-sale securities also decreased from ¥120 million to ¥60 million.
  4. FY2024Decrease in valuation difference and recognition of gain on sale of securitiesAnnual report

    「Special gains amounted to ¥432 million, owing mainly to the sale of cross-shareholdings and the recognition of gains on the sale of investment securities.」

    A ¥423 million gain on the sale of investment securities was recorded from the sale of cross-shareholdings, while the valuation difference on available-for-sale securities decreased from ¥335 million to ¥120 million.
  5. FY2024-Q2Decrease in valuation difference and recognition of gain on sale of securitiesAnnual report

    「Valuation difference on available-for-sale securities ¥335 million ¥295 million」

    The valuation difference on available-for-sale securities decreased from ¥335 million at the end of the previous consolidated fiscal year to ¥295 million. Meanwhile, a ¥293 million gain on the sale of investment securities was recorded.
  6. FY2024-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥335 million ¥389 million」

    The valuation difference on available-for-sale securities increased from ¥335 million at the end of the previous consolidated fiscal year to ¥389 million.
  7. FY2023MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥324 million ¥335 million」

    The valuation difference on available-for-sale securities increased from ¥324 million at the end of the previous fiscal year to ¥335 million, and no loss on valuation of investment securities was reported for the current fiscal year.
  8. FY2023-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥324 million ¥428 million」

    The valuation difference on available-for-sale securities increased from ¥324 million at the end of the previous consolidated fiscal year to ¥428 million. No loss on valuation of investment securities was reported for the cumulative period of the current quarter.
  9. FY2022-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities 357 368」

    The valuation difference on available-for-sale securities increased from ¥357 million at the end of the previous fiscal year to ¥368 million, and no loss on valuation of investment securities was recorded during the cumulative period of the current quarter.
  10. FY2021-Q3WorsenedAnnual report

    「In addition, a decline in the share prices of holdings resulted in an impairment loss on investment securities of ¥544 million.」

    A decline in the share prices of holdings resulted in an impairment loss on investment securities of ¥544 million.
  11. FY2021-Q2WorsenedAnnual report

    「In addition, as part of efforts to make effective use of its assets, the company moved to unwind its cross-shareholdings and recognized a gain on sales of investment securities of ¥54 million, but a decline in the share prices of holdings resulted in an impairment loss on investment securities of ¥513 million, recognized as an extraordinary loss.」

    A decline in the share prices of holdings resulted in an impairment loss on investment securities of ¥513 million.
  12. FY2021-Q1MaterialisedAnnual report

    「In addition, due to a decline in the share prices of holdings, an impairment loss on investment securities of ¥220 million was recognized as an extraordinary loss.」

    An impairment loss on investment securities of ¥220 million arose due to a decline in the share prices of holdings, contributing to the net loss.
  13. FY2020Annual update to impairment losses and gains on sales of sharesAnnual report

    「The recognition of impairment losses on investment securities, impairment losses and other items resulted in ¥58 million.」

    During the fiscal year, the company recognized an impairment loss on investment securities of ¥27 million, while also recognizing a gain on sales of investment securities of ¥258 million from the sale of cross-shareholdings.
  14. FY2020-Q3Update to cumulative impairment loss on investment securitiesAnnual report

    「Impairment loss on investment securities 215 242」

    The impairment loss on investment securities was ¥242 million in the cumulative third-quarter period, compared with ¥215 million in the same period of the previous year.
  15. FY2020-Q2MaterialisedAnnual report

    「Impairment loss on investment securities ¥255 million」

    An impairment loss on investment securities of ¥255 million due to a decline in the share prices of holdings was recognized during the cumulative second-quarter period.
  16. FY2020-Q1MaterialisedAnnual report

    「In addition, due to a decline in the share prices of holdings, an impairment loss on investment securities of ¥251 million was recognized as an extraordinary loss.」

    The decline in the share prices of holdings resulted in an actual impairment loss on investment securities of ¥251 million.
  17. FY2019MitigatedAnnual report

    「Net loss attributable to owners of the parent was ¥594 million, compared with net income of ¥823 million in the previous fiscal year. This was despite the reversal, due to the recovery in share prices, of the impairment loss on investment securities recognized in the third quarter, as the result was affected by the write-down of deferred tax assets under tax-effect accounting and other factors.」

    The impairment loss on investment securities recognized in the third quarter was reversed as share prices recovered.
  18. FY2019-Q3MaterialisedAnnual report

    「In addition, due to a decline in the share prices of holdings, an impairment loss on investment securities of ¥215 million was recognized as an extraordinary loss as of the end of the third quarter.」

    The decline in the share prices of holdings resulted in an actual impairment loss on investment securities of ¥215 million, which contributed to the quarterly net loss attributable to owners of the parent.
  19. FY2019-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities 421 151」

    The valuation difference on available-for-sale securities declined from ¥421 million at the end of the previous consolidated fiscal year to ¥151 million.
  20. FY2019-Q1WorsenedAnnual report

    「Valuation difference on available-for-sale securities 421 280」

    The valuation difference on available-for-sale securities declined from ¥421 million at the end of the previous consolidated fiscal year to ¥280 million.
  21. FY2018WorsenedAnnual report

    「Valuation difference on available-for-sale securities 533 421」

    The valuation difference on available-for-sale securities declined from ¥533 million at the end of the previous fiscal year to ¥421 million, and the decline in valuation continued.
  22. FY2018-Q3WorsenedAnnual report

    「Valuation difference on available-for-sale securities 533 477」

    The valuation difference on available-for-sale securities declined from ¥533 million at the end of the previous consolidated fiscal year to ¥477 million, and the contraction continued.
  23. FY2018-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities 533 486」

    The valuation difference on available-for-sale securities declined from ¥533 million at the end of the previous consolidated fiscal year to ¥486 million, reversing the increase through the end of the previous quarter and moving into a contraction.
  24. FY2018-Q1MitigatedAnnual report

    「Valuation difference on available-for-sale securities 533 549」

    The valuation difference on available-for-sale securities increased from ¥533 million at the end of the previous consolidated fiscal year to ¥549 million.
  25. FY2017MitigatedAnnual report

    「Net assets increased ¥1,098 million from the end of the previous consolidated fiscal year to ¥14,405 million, due mainly to the recognition of net income of ¥183 million attributable to owners of the parent, an increase in the valuation difference on available-for-sale securities due to rising share prices, and a decrease in the cumulative adjustment amount related to retirement benefits. The equity ratio was 34.73%.」

    The valuation difference on available-for-sale securities increased as share prices rose, recovering from the decline in valuation in the previous fiscal year.
  26. FY2017-Q3MitigatedAnnual report

    「Valuation difference on available-for-sale securities 278 489」

    The valuation difference on available-for-sale securities increased from ¥278 million at the end of the previous consolidated fiscal year to ¥489 million.
  27. FY2017-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities 278 351」

    The valuation difference on available-for-sale securities increased from ¥278 million at the end of the previous consolidated fiscal year to ¥351 million.
  28. FY2016RestatedAnnual report

    「Valuation difference on available-for-sale securities 414 278」

    On the consolidated balance sheet, the valuation difference on available-for-sale securities declined from ¥414 million to ¥278 million.
  29. FY2016-Q3First statedAnnual report

    「The main changes were attributable to a decline in deposits due to loan repayments and a decrease in the valuation of investment securities due to falling share prices, among other factors.」

    The disclosure describes the actual impact of the decline in the valuation of investment securities caused by falling share prices.
Moved together

"Expansion of sales in the Indian market" moved the same way as this thread, in the same document, in 12 of its 29 moves.

12121110109★123456
  1. ★This thread
  2. 1Expansion of sales in the Indian market12×
  3. 2Earnings improvement from operating loss to operating profit12×
  4. 3Economic slowdown in the Chinese market and adjustment of excess capacity11×
  5. 4Softness in the Machine Tool Industry10×
  6. 5Higher revenue and a return to operating profitability in the textile machinery business10×
  7. 6Uncertainty in Economic Conditions Due to Yen Appreciation, a Slowdown in the Chinese Economy, and Falling Resource Prices9×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
TSUDAKOMA Corp.'s next results are scheduled for 2026-10-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reduction in the Valuation of Investment Securities Due to Falling Share Prices | TSUDAKOMA Corp. (6217) | Komori